Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study

OBJECTIVE: Thyroid cancer can be detected in 5–10% of patients with thyroid nodules. Management may be a challenge if fine-needle aspiration biopsy yields Bethesda III findings. Most of these cases undergo surgery and are ultimately found benign. Our aim was to evaluate whether serum osteopontin can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kars, T U, Kulaksızoğlu, M, Kılınç, İ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265541/
https://www.ncbi.nlm.nih.gov/pubmed/37435186
http://dx.doi.org/10.1530/EO-21-0005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265541/
https://www.ncbi.nlm.nih.gov/pubmed/37435186
http://dx.doi.org/10.1530/EO-21-0005

Ejemplares similares